COVID-19 is the infectious pandemic disease caused by the novel
coronavirus. The COVID-19 is spread globally in a short span of
time. The Ministry of AYUSH, India which promotes Siddha and
other Indian system of medicine recommends the use of formulation
like Nilavembu Kudineer and Kaba Sura Kudineer Chooranam
(KSKC). The present work seeks to provide the evidence for the
action of 74 different constituents of the KSKC formulation acting
on two critical targets. That is main protease and SARS-CoV-2 RNAdependent
RNA polymerase target through molecular docking studies.
The molecular docking was done by using AutoDock Tools 1.5.6 of
the 74 compounds, about 50 compounds yielded docking results against
COVID-19 main protease while 42 compounds yielded against SARSCoV-
2 RNA-dependent RNA polymerase. This research has concluded
that the KSKC has the lead molecules that inhibits COVID-19’s target
of main protease of COVID-19 and SARS-CoV-2 RNA-dependent
RNA polymerase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.